pulmonary fibrosis
Conditions
Interventions
Group Assignments: Volunteers will be will be randomized in a simple way and directed to the groups for intervention assigned to groups for intervention. Thirty patients with post-COVID-19 pulmonary f
the irradiated group composed of 10 patients treated with conventional therapy associated with treatment with infrared photobiomodulation at 940 nanometers and the photobiomodulation group 2 composed
power density of 2.9 maxwell per square centimeter
and energy density of 2.6 Joules per square centimeter, representing a total optical energy of 5.4 kilojoules during the 900 seconds of irradiation. For con
E02.774
Sponsors
Centro Universitário de Itajubá
Clínica Escola de Fisioterapia no Centro Universitário de Itajubá - FEPI
Eligibility
Age
51 Years to 81 Years
Inclusion criteria
Inclusion criteria: Patients with post-COVID-19 pulmonary fibrosis; aged between 51 and 81 years; both genders
Exclusion criteria
Exclusion criteria: Patients with thromboembolic alterations such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism; tracheostomized; with a body mass index (BMI) >29.9 kgm2; who had neoplasms; history of photosensitivity; who had previously undergone Cardiopulmonary rehabilitation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the photobiomodulation technique with low-intensity light, using near-infrared LEDs, in association with cardiopulmonary rehabilitation through aerobic exercises, will be effective in the treatment of patients with post-COVID-19 pulmonary fibrosis | — |
Secondary
| Measure | Time frame |
|---|---|
| A positive effect of LED therapy on the lung function of post-COVID-19 patients is expected, in addition to the resulting improvement in respiratory muscle performance, through the analysis of Maximum Inspiratory Pressure (MIP) and Maximum Expiratory Pressure (MEP) and better performance cardiopulmonary by means of the distance covered in the 6MWT. We will find improvement in cardiopulmonary capacity through the Functional Status Scale (PCFS) and better clinical recovery of the patient through verification of pulse oximetry and complaint of dyspnea on exertion | — |
Countries
Brazil
Contacts
Public ContactPâmela Pereira
Centro Universitário de Itajubá
Outcome results
None listed